Endovascular Treatment of Primary Hepatic Tumours
Author Information
Author(s): Bogdan Popa, M. Popiel, L. Gulie, C. Turculeţ, M. Beuran
Primary Institution: Clinical Emergency Hospital Bucharest
Hypothesis
Endovascular interventional treatment is an effective alternative for unresectable primary hepatic tumours.
Conclusion
Endovascular treatment, particularly chemoembolization, is beneficial for patients with unresectable primary hepatic tumours.
Supporting Evidence
- Chemoembolization was found to be more effective than procedures without Lipiodol or embolic materials.
- After treatment, the diameter of tumours decreased gradually depending on the size of the tumour.
- Patients with Child C cirrhosis had contraindications for certain treatments, highlighting the need for tailored approaches.
Takeaway
Doctors can use a special treatment to help patients with liver tumors that can't be removed by surgery. This treatment helps shrink the tumors.
Methodology
The study involved patients with primary hepatic tumours treated with chemoembolization and intra-arterial chemotherapy, assessed through imaging techniques.
Limitations
The study mentions financial constraints affecting the number of reservoirs placed for treatment.
Participant Demographics
Patients included those with primary hepatic tumours, often associated with cirrhosis and viral infections.
Want to read the original?
Access the complete publication on the publisher's website